HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 7,285-7,296 of 27,277
Drug study icon
CompletedACTRN12616001351404

Safety study of ketamine in depression

Official study title

A single centre, double blind, randomised , parallel group, ascending single and multiple dose, safety and tolerability, pharmacokinetic and pharmacodynamic study of oral ketamine in healthy volunteer and patients with a history of depression or anxiety cohorts.

This study has finished and is no longer accepting participants.

In New Zealand
Depression, AnxietyInterventional studyAges 18–60
Countries
New Zealand
Sponsor
Zenith Technology Corp Ltd
Drug study icon
TerminatedNCT04232878

A Single Ascending Dose study of CVL-936 in Healthy Subjects

Official study title

A Phase 1, Double-Blind, Sponsor-Open, Placebo-Controlled, First-In-Human Trial To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Ascending Doses of CVL-936 In Healthy Subjects

This study ended early.

In Marlton
AddictionMedication studyAges 18–50
Countries
United States
Sponsor
Cerevel Therapeutics, LLC
Biological study icon
CompletedEUCTR 2010-019635-36

A Single Centre, Open-Label, Randomised Multi-Dose Study to Assess Changes in the Brain Metabolism of Juvenile ADHD Patients After Thirteen Weeks of Daily Intake of 4 g Superba Krill Oil or 4 g ome...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Iceland
ADHDHistorical research record
Countries
Iceland
Sponsor
Aker BioMarine Antarctic AS
Drug study icon
CompletedEUCTR 2008-006738-85

A Single Dose, Open-Label, Randomized, Two-Way Crossover Food Effect Study Comparing 12.5 mg FazaClo™ (clozapine) ODT under Fasted and Fed Conditions in Healthy Male Volunteers.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In United Kingdom
SchizophreniaHistorical research record
Countries
United Kingdom
Sponsor
Azur Pharma, Ltd.
Drug study icon
CompletedACTRN12617001258347

A Single-Center, Pharmacokinetic (PK) Study to Assess the PK Profile of Nicotine Delivered by the Chrono Quit Smoking Solution (CQSS2)

Official study title

A Single-Center, Open-Label Pharmacokinetic (PK) Study in male smokers to Assess the PK Profile of Nicotine Delivered by the Chrono Quit Smoking Solution (CQSS2)

This study has finished and is no longer accepting participants.

In Melbourne
AddictionInterventional studyAges 18+
Countries
Australia
Sponsor
Chrono Therapeutics Australia PTY LTD

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.